Latest Breaking News On - National cancer center hospital east - Page 10 : comparemela.com

Claudin-18 2 Emerges as a Novel Therapeutic Target in GI Malignancies

CLDN18.2 has become a promising target for the treatment of patients with digestive malignancies, such as gastric cancer, gastroesophageal junction cancer, esophageal cancer, and pancreatic cancer, because of its limited expression in healthy tissues and abnormal overexpression in a range of malignancies.

United statesKeymed biosciencesKohei shitaraAmerican society of clinical oncologyTranscenta holdingUniversity of texas md anderson cancer centerAstellas pharma incMalignant cellsClinical oncologyGastrointestinal cancers symposiumGastrointestinal oncologyNational cancer center hospital eastCancer centerNext stepsHolding limited

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

Multicenter VOLTAGE-2 Phase II Trial Will Conduct Exploratory Biomarker Analysis Using Highly-Sensitive Genomic Platforms from Personalis . | May 16, 2023

United statesRichard chenHideaki bandoNational cancer center hospital eastResearch secretariatDepartment of gastroenterologyNational cancer centerOno pharmaceutical co ltdPersonalis incPersonalis immunoExecutive vice presidentChief medical officerAssistant chiefPrincipal investigatorNc stock exchangePress release

Fujitsu Ltd: Fujitsu conducts project with Takeda and National Cancer Center Japan to analyze and visualize of patient journey with ovarian cancer

Providing validated analysis environment on Fujitsu's cloud-based platform for healthcare sector to empower patients with a personalized experienceTOKYO, May 12, 2023 - (JCN Newswire) - Fujitsu today announced

United statesKatsuya tsuchiharaExploratory oncology researchClinical trial centerDivision of translational informaticsHealth level seven incFujitsu ltdInvestor relations divisionInternational society for pharmacoeconomicsOutcomes researchTakeda pharmaceutical companyFujitsu limitedNational cancer center japanHealth level seven fast healthcare interoperability resourceNational cancer center hospitalTakeda pharmaceutical company limited

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKatsuya tsuchiharaHealth level seven fast healthcare interoperability resourceDivision of translational informaticsTakeda pharmaceutical companyInvestor relations divisionExploratory oncology researchClinical trial centerNational cancer center hospitalInternational society for pharmacoeconomicsNational cancer center japanHealth level seven incFujitsu ltdOutcomes researchFujitsu limitedTakeda pharmaceutical company limited

Fujitsu conducts project with Takeda and National Cancer Center Japan to analyze and visualize of patient journey with ovarian cancer

Fujitsu conducts project with Takeda and National Cancer Center Japan to analyze and visualize of patient journey with ovarian cancer
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKatsuya tsuchiharaInternational society for pharmacoeconomicsDivision of translational informaticsNational cancer center hospitalTakeda pharmaceutical companyClinical trial centerExploratory oncology researchFujitsu limitedHealth level seven incHealth level seven fast healthcare interoperability resourceJapan corporate news networkInvestor relations divisionOutcomes researchFujitsu ltdNational cancer center japan